Skip to main content
All lobbying filings

PFIZER INC.

Lobbying for PFIZER INC.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $3,490,000.00 expenses · posted Jul 21, 2025

Official filing document

 Bills named in this filing 5
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HR 946
    ORPHAN Cures Act
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • HR 2214
    DRUG Act
  • HR 2450
    Prescription Drug Transparency and Affordability Act
 Lobbying activity 5
Trade (domestic/foreign)

International Supply Chain Global Access Tariffs Non-Tariff Trade Barriers

Budget/Appropriations

HR 1 - One Big Beautiful Bill Act CDC Reform Vaccine Policy Reconciliation Research & Development

Health Issues

S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 832 - EPIC Act of 2025 HR 1 - One Big Beautiful Bill Act CDC Reform Vaccine Policy Reconciliation Research & Development HR 946 - ORPHAN Cures Act HR 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program HR 2214 - DRUG Act HR 2450 - Prescription Drug Transparency and Affordability Act PL 117-328 Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Biosimilars Access, Reimbursement and Reform 340B Reform Prescription Drug User Fee Act (PDUFA) Inflation Reduction Act (IRA) Pill Penalty Vaccine Coverage and Access Intellectual Property Protections PBM Reform Cancer Policies Drug Pricing

Medicare/Medicaid

S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 832 - EPIC Act of 2025 HR 946 - ORPHAN Cures Act HR 2450 - Prescription Drug Transparency and Affordability Act Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform Medicaid Prescription Drug Access Digital Therapeutics

Taxation/Internal Revenue Code

VICP Reform and Excise Tax Vaccine Injury Compensation Program

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem